Form 8-K - Current report:
SEC Accession No. 0001104659-06-031238
Filing Date
2006-05-04
Accepted
2006-05-04 17:04:49
Documents
4
Period of Report
2006-04-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-11249_18k.htm 8-K 22751
2 EX-99 a06-11249_1ex99d1.htm EX-99.1 7493
3 GRAPHIC g112491kei001.jpg GRAPHIC 12705
4 GRAPHIC g112491kei002.jpg GRAPHIC 12219
  Complete submission text file 0001104659-06-031238.txt   66461
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 06809307
SIC: 2836 Biological Products, (No Diagnostic Substances)